Repro Med Systems (KRMD) Reports In-Line Q2 EPS; Offers FY23 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. SPY
10. FISV

Go back to Repro Med Systems (KRMD) Reports In-Line Q2 EPS; Offers FY23 Revenue Guidance

KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook

August 9, 2023 4:05 PM EDT

MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the second quarter ended June 30, 2023 and updates full year 2023 outlook.

Highlights:

Second quarter net revenue growth versus prior year of 6% to $6.9 million Domestic Core business growth of 8%, outperforming a second quarter U.S. script decline in subcutaneous... More